24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
09/11/2016
Barcelona, a Bright Spot in the European Digital Landscape
02/11/2016
Malaysia Comes to Discover the Barcelona DC Cluster Initiative Set Up In Barcelona Synchrotron Park
26/10/2016
MIRAS New ALBA Synchrotron Beamline Goes Under Researchers Skin
19/10/2016
Christian Ketels: “Thanks to clusters, Catalonia is much more attractive to foreign companies”
11/10/2016
Barcelona DC Cluster Initiative
06/10/2016
Barcelona Synchrotron Park Sponsors the Fifth Ideas Generation Program